Health-related quality of life after Rituximab treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are severe, socially significant diseases that require a clear understanding of the relationship between the current health status and quality of life of patients. On the one hand, in the scientific literature, there is not enou...
Saved in:
Main Authors: | Iva Parvova (Author), Tzvetomir Delyiski (Author), Parvoleta Peteva (Author), Valentina Petkova (Author), Irfan Irfan (Author), Emanuil Yordanov (Author), Emil Hristov (Author) |
---|---|
Format: | Book |
Published: |
Pensoft Publishers,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-interventional observational retrospective-prospective study of health-related quality of life (EuroQoL) in patients with vasculitis associated with antineutrophil cytoplasmic antibodies undergoing treatment with rituximab
by: Iva Parvova, et al.
Published: (2024) -
Systemic vasculitis associated with anti neutrophil cytoplasmic antibodies in Bulgaria - epidemiological, health-demographic and clinical-pharmacological real-world data
by: Iva Parvova, et al.
Published: (2024) -
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
by: Moog P, et al.
Published: (2015) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Zhi-Ying Li, et al.
Published: (2020) -
Application of biological medicinal products and tyrosine kinase inhibitors in rheumatoid arthritis and COVID-19: A systematic review of scientific literature
by: Iva Parvova, et al.
Published: (2024)